![David Montecalvo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Montecalvo
Direktor/Vorstandsmitglied bei
Olin Business School
Profil
David A. Montecalvo ist SVP, Chief Operations & Supply Chain Officer bei West Pharmaceutical Services, Inc. In der Vergangenheit war er Vice President-Operations bei Urologix, Inc. und Vice President-Contract Manufacturing Operations bei Medtronic Plc sowie Vice President-Product Development & Operations bei Medtronic CardioVascular (einer Tochtergesellschaft von Medtronic Plc). Er erhielt einen MBA von der St. Thomas University (Florida) und einen Bachelor-Abschluss von der Case Western Reserve University.
Aktive Positionen von David Montecalvo
| Unternehmen | Position | Beginn |
|---|---|---|
Olin Business School
 Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.02.2017 |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Berater | 01.10.2022 |
Vance Street Management LLC
 Vance Street Management LLC Investment ManagersFinance Vance Street invests in middle market companies located in the United States or Canada with an enterprise values of USD 30 - 350 million and EBITDA of USD 3 - 30 million. The firm focuses on medical, industrial technology, life science, aerospace and defense. It provides financing for management buyouts, recapitalizations of family businesses, corporate carve-outs, add on acquisitions, industry consolidations and growth capital requirements. | Private Equity Investor | 01.09.2024 |
Ehemalige bekannte Positionen von David Montecalvo
| Unternehmen | Position | Ende |
|---|---|---|
Sterlingtech, Inc.
 Sterlingtech, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Vorstandsvorsitzender | 01.11.2023 |
| WEST PHARMACEUTICAL SERVICES, INC. | Geschäftsführer | 12.05.2022 |
RBC Development LLC
 RBC Development LLC Packaged SoftwareTechnology Services Develops designs and manufacturing services for medical technology company | Vorstandsvorsitzender | - |
Medtronic CardioVascular
 Medtronic CardioVascular Medical SpecialtiesHealth Technology Manufactures medical devices | Geschäftsführer | - |
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Ausbildung von David Montecalvo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Urologix, Inc.
 Urologix, Inc. Medical SpecialtiesHealth Technology Manufactures, develops and markets minimally invasive urological treatment products | Health Technology |
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Thomas University (Florida)
 St. Thomas University (Florida) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic CardioVascular
Medtronic CardioVascular Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Vance Street Management LLC
Vance Street Management LLC Investment ManagersFinance Vance Street invests in middle market companies located in the United States or Canada with an enterprise values of USD 30 - 350 million and EBITDA of USD 3 - 30 million. The firm focuses on medical, industrial technology, life science, aerospace and defense. It provides financing for management buyouts, recapitalizations of family businesses, corporate carve-outs, add on acquisitions, industry consolidations and growth capital requirements. | Finance |
Olin Business School
Olin Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medtronic Plc
 Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Sterlingtech, Inc.
Sterlingtech, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices | Health Technology |
RBC Development LLC
RBC Development LLC Packaged SoftwareTechnology Services Develops designs and manufacturing services for medical technology company | Technology Services |
